[1] |
VAN DER HAM K, LOUWERS Y V, LAVEN J S E. Cardiometabolic biomarkers in women with polycystic ovary syndrome[J]. Fertil Steril, 2022, 117(5):887-896.
DOI
PMID
|
[2] |
EZEH U, PISARSKA M D, AZZIZ R. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome[J]. Hum Reprod, 2022, 37(3):553-564.
|
[3] |
JOHAM A E, NORMAN R J, STENER-VICTORIN E, et al. Polycystic ovary syndrome[J]. Lancet Diabetes Endocrinol, 2022, 10(9):668-680.
|
[4] |
GAO L, ZHAO Y, WU H, et al. Polycystic ovary syndrome fuels cardiovascular inflammation and aggravates ischemic cardiac injury[J]. Circulation, 2023, 148(24):1958-1973.
DOI
PMID
|
[5] |
LIAO C C, CHIEN C H, YU T S, et al. Integrated Chinese and western medicine for coronary heart disease prevention in polycystic ovary syndrome:a 19-year nationwide cohort study[J]. J Multidiscip Healthc, 2023, 16:3959-3973.
|
[6] |
WU L, SHAO P, GAO Z, et al. Homocysteine and Lp-PLA2 levels:diagnostic value in coronary heart disease[J]. Medicine(Baltimore), 2023, 102(46):e35982.
|
[7] |
KAZEROONI T, GHAFFARPASAND F, ASADI N, et al. Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome:a comparative study[J]. J Chin Med Assoc, 2013, 76(5):282-288.
|
[8] |
KARADENIZ M, ERDOGAN M, ZENGI A, et al. Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome[J]. Endocrine, 2010, 38(1):127-133.
DOI
PMID
|
[9] |
Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J]. Hum Reprod, 2004, 19(1):41-47.
|
[10] |
章永川, 林金仙. 胰岛素抵抗对代谢紊乱的影响[J]. 浙江临床医学, 2000, 2(6):373-374.
|
[11] |
朱琳, 陈跃瑜, 林延润, 等. PCOS患者MTHFR C677T基因多态性与胰岛素峰值后移的相关性研究[J]. 现代检验医学杂志, 2023, 38(6):54-58.
|
[12] |
GUNNING M N, SIR PETERMANN T, CRISOSTO N, et al. Cardiometabolic health in offspring of women with PCOS compared to healthy controls:a systematic review and individual participant data meta-analysis[J]. Hum Reprod Update, 2020, 26(1):103-117.
|
[13] |
LI Y, ZHANG H, JIANG C, et al. Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue[J]. J Biol Chem, 2013, 288(14):9583-9592.
DOI
PMID
|
[14] |
NSRALLAH A A, ABD-EL FATAH A H, AHMED H S. Genetic polymorphism of methylenetetrahydrofolate reductase is associated with insulin resistance in Egyptian women with polycystic ovary syndrome[J]. J Gene Med, 2019, 21(4):e3076.
|
[15] |
MOLL S, VARGA E A. Homocysteine and MTHFR mutations[J]. Circulation, 2015, 132(1):e6-e9.
|
[16] |
ZHU X, HONG X, CHEN L, et al. Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with genetic susceptibility to polycystic ovary syndrome:a PRISMA-compliant meta-analysis[J]. Gene, 2019, 719:144079.
|
[17] |
王玲玲, 郭志国, 陶晓明, 等. 亚甲基四氢叶酸还原酶基因多态性及甲状腺功能与妊娠期糖尿病的相关性[J]. 中国实验诊断学, 2021, 25(6):825-829.
|
[18] |
KHERADMAND M, MAGHBOOLI Z, SALEMI S, et al. Associations of MTHFR C677T polymorphism with insulin resistance,results of NURSE study(nursing unacquainted related stress etiologies)[J]. J Diabetes Metab Disord, 2017, 16:22.
|
[19] |
TAVAKKOLY BAZZAZ J, SHOJAPOOR M, NAZEM H, et al. Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity[J]. Mol Biol Rep, 2010, 37(1):105-109.
DOI
PMID
|
[20] |
ORIO F Jr, PALOMBA S, DI BIASE S, et al. Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2003, 88(2):673-679.
|
[21] |
SOLINI A, SANTINI E, FERRANNINI E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects[J]. Int J Obes(Lond), 2006, 30(8):1197-1202.
|
[22] |
GARGARI B P, AGHAMOHAMMADI V, ALIASGHARZADEH A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes[J]. Diabetes Res Clin Pract, 2011, 94(1):33-38.
|